Journal ArticleDOI
Jak rozpoznawać i leczyć chorobę Gauchera: zarys patofizjologii, objawów klinicznych, metod diagnostycznych i leczenia
TLDR
This review highlights pathophysiology, signs and symptoms, diagnostic and therapeutic principles of Gaucher disease, a rare autosomal recessive lipid storage disorder caused by the deficient activity of the lysosomal enzyme glucocerebrosidase.Abstract:
Rare diseases are a diagnostic challenge for modern medicine. Gaucher disease is a rare autosomal recessive lipid storage disorder caused by the deficient activity of the lysosomal enzyme glucocerebrosidase. In the absence of known affected family member, frequent symptoms of Gaucher disease, such as thrombocytopenia or splenomegaly, often lead to hematological diagnostic workup. This review highlights pathophysiology, signs and symptoms, diagnostic and therapeutic principles of Gaucher disease. Difficulties in diagnosis of Gaucher disease depends mainly on its rarity, but there is also the lack of awareness and limited knowledge about this disease. Basic knowledge of Gaucher disease should be familiar to all physicians, including hematologists.read more
References
More filters
Journal ArticleDOI
Metabolism of glucocerebrosides. ii. evidence of an enzymatic deficiency in gaucher's disease.
Journal ArticleDOI
Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).
TL;DR: The spectrum of GBA mutations and their distribution in the patient population, evolutionary conservation, clinical presentations, and how they may affect the structure and function of glucocerebrosidase are discussed.
Journal ArticleDOI
Phenotype, diagnosis, and treatment of Gaucher's disease.
TL;DR: The ability to safely and effectively use enzyme therapy to inhibit or reverse visceral-disease progression and involvement has provided impetus for design of new enzyme therapies, and creation of substrate depletion and pharmacological chaperone strategies.
Journal ArticleDOI
A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments
Jérôme Stirnemann,Nadia Belmatoug,Fabrice Camou,Christine Serratrice,Roseline Froissart,Catherine Caillaud,Thierry Levade,Leonardo Astudillo,Jacques Serratrice,Anaïs Brassier,Christian Rose,Thierry Billette de Villemeur,Marc G. Berger +12 more
TL;DR: Type-1 Gaucher disease, which affects the majority of patients (90% in Europe and USA, but less in other regions), is characterized by effects on the viscera, whereas types 2 and 3 are also associated with neurological impairment, either severe in type 2 or variable in type 3.
Journal ArticleDOI
Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages.
Leonie A. Boven,Marjan van Meurs,Rolf G. Boot,Atul Mehta,Louis Boon,Johannes M. F. G. Aerts,Jon D. Laman +6 more
TL;DR: GCs represent a distinctive population of myeloid cells that resemble aamphi but differ from previously described in vitro aamph, and are investigated by using immunohistochemical analysis.